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Abstract
Background: Proopiomelanocortin (POMC) neurons in the arcuate nucleus of the hypothalamus (ARH) control energy
homeostasis by sensing hormonal and nutrient cues and activating secondary melanocortin sensing neurons. We
identified the expression of a G protein-coupled receptor, Gpr17, in the ARH and hypothesized that it contributes to
the regulatory function of POMC neurons on metabolism.
Methods: In order to test this hypothesis, we generated POMC neuron-specific Gpr17 knockout (PGKO) mice and
determined their energy and glucose metabolic phenotypes on normal chow diet (NCD) and high-fat diet (HFD).
Results: Adult PGKO mice on NCD displayed comparable body composition and metabolic features measured by indirect
calorimetry. By contrast, PGKO mice on HFD demonstrated a sexually dimorphic phenotype with female PGKO mice
displaying better metabolic homeostasis. Notably, female PGKO mice gained significantly less body weight and adiposity
(p < 0.01), which was associated with increased energy expenditure, locomotor activity, and respiratory quotient, while
males did not have an overt change in energy homeostasis. Though PGKO mice of both sexes had comparable glucose
and insulin tolerance, detailed analyses of liver gene expression and serum metabolites indicate that PGKO mice could
have reduced gluconeogenesis and increased lipid utilization on HFD. To elucidate the central-based mechanism(s)
underlying the better-preserved energy and glucose homeostasis in PGKO mice on HFD, we examined the
electrophysiological properties of POMC neurons and found Gpr17 deficiency led to increased spontaneous action
potentials. Moreover, PGKO mice, especially female knockouts, had increased POMC-derived alpha-melanocyte stimulating
hormone and beta-endorphin despite a comparable level of prohormone POMC in their hypothalamic extracts.
Conclusions: Gpr17 deficiency in POMC neurons protects metabolic homeostasis in a sex-dependent manner during
dietary and aging challenges, suggesting that Gpr17 could be an effective anti-obesity target in specific populations with
poor metabolic control.
Introduction
Chronic food intake in excess of energy expenditure
leads to adiposity gain and obesity. Proopiomelanocortin
(POMC) neurons in the arcuate nucleus of the hypotha-
lamus (ARH) control energy homeostasis through the
production of alpha-melanocyte stimulating hormone (α-
MSH), a POMC-derived peptide which activates mela-
nocortin receptors 3 and 4 (MC3/4R)1–5. Human patients
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with loss-of-function mutations in POMC or MC3/4R
have persistent hunger and consequently develop obe-
sity5,6, highlighting the crucial role of melanocortin sig-
naling in managing energy balance. Neurons co-
expressing Agouti-related peptide and Neuropeptide Y
(AgRP/NPY) in the ARH decrease satiety by opposing the
functions of POMC neurons via GABAergic projections
onto POMC neurons and the secretion of AgRP and NPY
neuropeptides7–12. POMC neurons and AgRP/NPY neu-
rons have divergent responses to adiposity signals13–15.
Given the pivotal role of POMC neurons in regulating
metabolic homeostasis, our research objective was to
identify novel mechanisms controlling POMC neuronal
activity that can be leveraged for treating obesity.
Although the role of POMC neurons in managing
energy balance is well established, the biological
mechanisms regulating their activity is still an area under
active investigation. Forkhead box protein O1 (FoxO1)
protein was detected in the hypothalamic AgRP and
POMC neurons, and hypothalamic expression of a con-
stitutive active form of FoxO1 resulted in a loss of the
ability of leptin to curtail food intake16. Carboxypeptidase
E (Cpe), an enzyme that mediates POMC processing, was
identified as a FoxO1 transcriptional target in POMC
neurons17. We, as well as other groups, identified Gpr17
as a transcriptional target of FoxO1 in the central nervous
system18,19. Furthermore, we generated Gpr17 conditional
knockout mice and analyzed its metabolic function in
AgRP neurons18.
Based on emerging evidence that the orphan receptor
Gpr17 is expressed by neuronal populations involved in
energy homeostasis18,20, we hypothesized that
Gpr17 signaling regulates POMC neuronal function to
control appetite, metabolism, and energy homeostasis. In
order to test this hypothesis, we generated POMC neuron-
specific Gpr17 knockout mice and determined their basal
metabolic features. Gender differences exist in regulation of
metabolism21. POMC neurons exhibit sexual dimorphism
in the regulation of energy homeostasis22,23. Moreover,
aging and unhealthy diet are known factors associated with
adiposity gain, a major contributor to insulin resistance and
metabolic derangements. Therefore, in this study, we ana-
lyzed the metabolic phenotype of both female and male
mice at different ages challenged with chronic feeding of
high-fat diet. Our systemic characterization of the mutant
mice of both sexes revealed that Gpr17 deficiency in POMC
neurons ameliorated the metabolic derangements caused by
long-term high-fat diet feeding, which was more pro-
nounced in female mice.
Materials and methods
Experimental animals
Pomc promoter-driven Gpr17 knockout (PGKO) mice
were generated by cross-breeding Pomc-Cre mice24 and
Gpr17 lox/lox mice20. Pomc-Cre negative, Gpr17 lox/lox
mice, or Pomc-Cre;Gpr17 lox/+mice were used as con-
trols for all experiments. All mice were maintained in the
Columbia University or IUSM Lab animal resource center
(LARC) facility. The procedures were approved by the
Columbia University Animal Care and Utilization Com-
mittee and Indiana University Animal Care and Use
Committee (IACUC). Mice were weaned at 3 weeks old
and group housed (3–5 mice per cage) except during
indirect calorimetry measurements (1 mouse per cage).
Animals were assigned for experiments blinded and
genetic information was revealed only after experiment
was completed.
Feeding regimen
Experimental animals were fed with either normal chow
diet (NCD) or high-fat diet (HFD). NCD had 62.1% of
calories from carbohydrates, 24.6% from protein, and
13.2% from fat (PicoLab Rodent Diet 20, catalog #5053;
Purina Mills. In order to induce obesity, we used high-fat
diet (HFD) containing 60% calories from fat, 20% from
protein, 20% from carbohydrate (Research Diets, catalog
#D12492, New Brunswick, NJ). We profiled the metabolic
phenotype in adult cohorts fed NCD, HFD for
4–5 months and for 8–10 months (i.e., long-term HFD) as
indicated by the figure legends.
Serum biochemistries
Mouse serum was collected by tail vein bleeding or
terminal cardiac puncture. In order to characterize the
metabolic flexibility of mice, we analyzed serum meta-
bolite concentrations during ad libitum feeding, short
fasting during daytime (5 h), overnight fasting (~16 h),
and refeeding (4–5 h of ad libitum feeding after overnight
fasting). We measured free glycerol (Sigma cat. no.
F6428), free cholesterol (Wako cat. no. 993-02501), and
non-esterified free fatty acid (Wako cat. nos. 999-34691,
995-34791, 991-34891, 993-35191) by colorimetric enzy-
matic assays. We used ELISAs to measure serum leptin
(EMD Millipore cat. no. EZML-82K), and serum insulin
(EMD Millipore cat. no. EZRMI-13K). All reactions were
performed according to manufacturer protocols.
Indirect calorimetry
Indirect calorimetry measurements (food intake, energy
expenditure, respiratory quotient, and locomotor activity)
were collected using a TSE PhenoMaster Platform (TSE
Systems, Chesterfield, MO) as described previously25,
except for the female long-term HFD cohort. Briefly, mice
were single-housed for the duration of metabolic analysis
and were allowed to acclimate for 48 h before analysis.
Data were collected every 51min during a normal 12-h
day/night cycle. Mice had ad libitum access to normal or
high-fat diet chow. Total body weight and lean mass were
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determined beforehand by MRI scan (EcoMRI-100,
EcoMRI Houston, TX) for calculating indirect calorimetry
measurements. Long-term HFD females were analyzed on
Comprehensive Laboratory Animal Monitoring System
(CLAMS, Oxymax Windows 3.0.3; Columbus Instru-
ments). CLAMS data were collected in the same manner
at 17–30min intervals during a normal 12-h day/
night cycle.
Quantification of POMC and POMC-derived peptides
PGKO and control mice aged 3–6 months were
exposed to HFD for 2 weeks, then sacrificed after ad
libitum feeding and peptides were measured in acid
extracts of dissected medial basal hypothalamic samples
as previously described26. POMC was measured by 2-
site ELISA with antibodies provided by Dr. Anne White
(University of Manchester, UK); there is no cross-
reactivity with α-MSH or β-EP26. α-MSH and β-EP were
measured by radioimmunoassay (RIA)26. The β-EP
antibody fully cross-reacts with β-EP (1–31), β-EP
(1–26), and β-EP (1–27) and 2.6% with POMC on a
molar basis. The α-MSH antibody fully cross-reacts with
desacetyl α-MSH; there is no cross-reactivity with β-EP,
adrenocorticotropin hormone (ACTH), or POMC. The
total protein concentration was measured in each
hypothalamic sample and used for normalization in
order to minimize the variability of individual sample
dissection and extraction.
Glucose tolerance test and insulin tolerance test
Glucose tolerance test (GTT) was performed as
described previously25 in PGKO and WT mice fed HFD
for 4–5 months. Briefly, we injected a bolus of glucose
solution intraperitoneally (1 g/kg in males and 2 g/kg in
females) after an overnight fast (~16 h). Blood glucose
concentrations were measured from drops of tail blood at
the indicated time points using a glucose meter (Bayer
Breeze2). In order to determine the sensitivity of periph-
eral tissues to insulin, we performed insulin tolerance
tests (ITT) to mice after 6 h of fasting. We delivered
1.5 Units/kg of insulin (Novo Nordisk) by intraperitoneal
injection and recorded tail blood glucose concentration
over time (0, 15, 30, 60, 90 min).
Gene expression
Livers and brains were collected from mice euthanized
with CO2 after feeding as indicated in the corresponding
figure legend. We extracted RNA with TRIzol Reagent
(Invitrogen) and used Superscript II reverse transcriptase
(Invitrogen) to synthesize template cDNA for quantitative
RT-PCR. We PCR amplified target DNA with primers
spanning introns. Primer sequences are available upon
request. All reactions were performed according to
manufacturer protocols.
Statistical comparisons
We used GraphPad Prism software for statistical ana-
lyses and graphics generation. Data are presented as
average ± standard error. Comparisons were made
between age-matched control and knockout littermates.
Statistical tests and group sizes are specified in the cor-
responding Figure legend. Sample exclusion criteria were
predetermined. For endpoint experiments, we excluded
outliers more than 2 SD from the group mean. Mice with
clearly abnormal behavior, such as hyperlocomotion or
lack of food intake, were excluded from metabolic
analysis.
Electrophysiology, histology, and fluorescence activated
cell sorting (FACS)
Detailed methods are described in ‘Supplemental
Methods’.
Results
PGKO male and female mice have normal body weight and
composition on normal chow diet (NCD)
In order to understand the physiological role of Gpr17
in POMC neurons, we specifically knocked out Gpr17 in
POMC neurons (Pomc-Cre;Gpr17 lox/lox mice, hereafter
called PGKO mice). PGKO mice were compared with
littermate control mice in individual cohorts (hereafter
called wild-type (WT) mice).
In order to characterize the specificity and efficiency of
Cre-dependent knockout, we first extracted genomic
DNA from various tissues and were able to detect the
recombined allele in the mediobasal hypothalamus (mbh)
but not in other tissues (Fig. S1A, arrow). In order to
specifically assess the gene expression of Gpr17 in POMC
neurons in the WT and PGKO mice, we used the fluor-
escence activated cell sorting (FACS) of live dissociated
hypothalamic cells. We introduced a reporter Rosa-
tdTomato to specifically label POMC neurons in WT
and PGKO mice, then collected the Tomato+ cell
population for gene expression analysis with RT-PCR.
Gpr17 transcript was virtually undetectable in the POMC
neurons of the PGKO mice, while it was detected in the
POMC neurons of the WT mice as well as the input
fractions (Fig. S1B–D). FACS successfully enriched the
Pomc transcripts (~400 fold) in the Tomato+ fraction,
which further validated our method (Fig. S1E). Overall,
this set of experiments demonstrated the successful and
specific ablation of Gpr17 expression in the POMC neu-
rons of PGKO mice.
We characterized body composition and energy home-
ostasis in PGKO mice on normal chow diet. PGKO males
and females had comparable total body weight with
control males and females, respectively (Fig. 1a, b). We
measured body composition with MRI and found that fat
mass (percentage of body weight) and lean mass
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(percentage of body weight) were similar between PGKO
and control mice (Fig. 1c, d). Therefore, we concluded
that PGKO mice on a normal chow diet were able to
maintain a healthy body weight and composition similarly
to control mice without an apparent defect in growth or
energy balance.
Feeding and energy balance in NCD-fed PGKO mice
We used indirect calorimetry to determine whether male
and female PGKO mice had differences in energy home-
ostasis on NCD. PGKO mice showed comparable measures
compared with control mice in terms of energy expenditure
(i.e., heat production, Fig. 2a–d), food intake (Fig. 2e–h),
respiratory quotient (Fig. 2i–l), oxygen consumption
(Fig. 2m–p), and locomotor activity (Fig. 2q–t). Since
caloric intake and energy expenditure were similar between
control and PGKO mice, mice did not develop different
body weight/composition (Fig. 1a–d). The metabolism of
glucose and fatty acids produces different respiratory quo-
tients (volumetric CO2:O2 ratio) because of their different
reaction stoichiometries. Respiratory quotient indicated that
metabolic flexibility between carbohydrate or lipid meta-
bolism was sustained for PGKO mice (Fig. 2m–p). Noc-
turnal locomotor activity (Fig. 1q–t) showed that PGKO
mice had intact feeding behaviors in diurnal and nocturnal
phases. Overall, PGKO mice did not have an overt meta-
bolic phenotype when maintained on NCD.
High-fat diet changes metabolism and feeding behaviors
of PGKO mice in a sex-dependent manner
Since normal chow is a nutritionally balanced diet not
sufficient to cause obesity, we decided to challenge PGKO
mice with high-fat diet (HFD) containing 60% kcal from
fat, 20% from protein, 20% from carbohydrate to reveal
disparities in regulating energy homeostasis. One-year-old
mice male and female mice were fed HFD for 3 and
5 months, respectively. We used indirect calorimetry to
measure key metabolic features in both male and female
mice and observed sexually dimorphic metabolic pheno-
types. Male PGKO mice did not have statistically different
energy expenditure during light or dark phases (Fig. 3a, b).
By contrast, energy expenditure in female mice trended
upward for light and dark phases but did not reach sig-
nificance (Fig. 3c, d). Twenty-four hours of food intake
was not significantly different in either the male or female
groups (Fig. 3e–h). Together, these data suggested that
female PGKO mice had better energy balance. Respiratory
quotient was similar in male mice (Fig. 3i–j) but was
significantly increased in female mice (Fig. 3k, l), indi-
cating more glucose utilization in PGKO female mice.
Oxygen consumption was not altered in male mice
(Fig. 3m, n) but was significantly increased in female mice
(Fig. 3o, p). We measured locomotor activity during the
light and dark phase in PGKO mice (Fig. 3q–t) and found
that female mice had significantly increased locomotor
activity during the dark phase. Taken together, PGKO
females appeared to have better energy balance and we
predicted that these mice may resist weight gain with
prolonged high diet feeding.
PGKO mice resisted weight and adiposity gained from
long-term HFD
In order to determine if improved energy balance pre-
dicted lower weight gain, we continued to feed HFD to the
same cohorts used for the indirect calorimetry experiment
(Fig. 3). Indeed, we discovered that after long-term HFD,
male and female PGKO mice had lower total body weight
(Fig. 4a, c, respectively) and epididymal white adipose
tissue (EWAT) mass (Fig. 4b, d). Total body weight and
EWAT mass trended lower in PGKO males but did not
reach statistical significance (p= 0.09); however, weight
gained from five additional months of HFD was sig-
nificantly lower (Fig. 4f). The female PGKO group was
even more protected from the diet-induced weight gain,
having reduced body weight gain (Fig. 4g, h) and EWAT
mass at the end of the experiment (Fig. 4d).
PGKO mice have sex-dependent changes in serum
metabolite concentrations and hepatic glycolytic enzyme
expression
In order to determine if PGKO mice had altered
nutrient metabolism compared with control mice, we
measured the blood glucose and the serum concentration
of various metabolites in other PGKO cohorts fed HFD.
We determined that blood glucose levels during fasting-
refeeding, glucose tolerance, and insulin tolerance were
Fig. 1 PGKO male and female mice have normal body weight and
composition on NCD. Left-hand data are male mice, right-hand data
are female mice. Body weight in grams is presented for males (a) and
females (b). Fat and lean mass percentage for male (c) and female (d)
mice were measured with MRI prior to indirect calorimetry. Statistical
comparisons with unpaired student’s t-test were non-significant (n=
8, 7 males; n= 9, 7 females). Data shown are average ± standard error
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indistinguishable in PGKO mice (Fig. S2A–F). Then, we
assessed whether the expression of key hepatic genes for
glucose and lipid metabolism in PGKO mice was altered.
We measured hepatic mRNA transcripts involved in
glycolysis, gluconeogenesis, and fatty acid synthesis for
males and females. In males, we found a trending decrease
in glucokinase (Gck) and a significant twofold increase in
pyruvate dehydrogenase kinase 4 (Pdk4) transcript (Fig.
S2G). In female PGKO mice (Fig. S2H), we found a sig-
nificant increase in glucokinase expression and trend for
increased Pdk4. Pck1 (encoding phosphoenylpyruvate
carboxykinase) and Pdk4 transcripts trended higher than
control mice. Glucokinase is a target gene of insulin sig-
naling through the sterol regulatory element binding
transcription factor 1 (Srebp1c), which trended lower in
PGKO males and females. When we profiled serum
metabolite concentrations, we found male and female
PGKO mice had sexually dimorphic alterations in several
metabolites (Table 1). For male PGKO mice, triglyceride
and glycerol concentration were increased during ad
libitum feeding and short fast, respectively, indicating
increased lipolysis. In female PGKO mice, there was a
significant increase in non-esterified fatty acid during ad
libitum feeding, and lower cholesterol during overnight
Fig. 2 PGKO mice display comparable metabolic features as wild-type mice without dietary challenge. Left-hand figures are male mice; right-
hand figures are female mice. We determined energy expenditure normalized to lean mass (a–d), total 24-h food intake (e–h), respiratory quotient
(i–l), and oxygen consumption (m–p). Locomotor activity was measured by counting the number of floor beam breaks (q–t). Bar graphs are the 12-h
average of data shown in corresponding line graph, separated into light and dark phases of the light cycle. Statistical comparisons with unpaired
student’s t-test were non-significant (n= 8, 7 males; n= 9, 7 females). Data shown are average ± standard error
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fasting and refeeding. We concluded PGKO mice have
increased peripheral metabolism of lipids and that hepatic
enzymes were differently regulated to favor lipid utiliza-
tion in PGKO mice, which could lead to the reduced
adiposity gain after prolonged HFD feeding.
PGKO mice have sex-dependent increases in POMC
processing
POMC-derived neuropeptides play critical physiological
functions, including appetite regulation27. α-MSH is
anorexigenic, while the effect of β-endorphin (β-EP) on
Fig. 3 High-fat diet changes metabolism and feeding behaviors of PGKO mice in a sex-dependent manner. Mice were fed a long-term HFD
ad libitum, then single-housed in metabolic caging for indirect calorimetry. Data shown are for ad libitum feeding during a 24-h window (12 h of
light and dark as indicated on the x-axes). Left-hand figures are male data, right-hand figures are female data. We determined energy expenditure
normalized to body weight (a–d), total 24-h food intake (e–h), respiratory quotient (i–l), and oxygen consumption (m–p). Locomotor activity was
measured by counting the number of floor beam breaks (q–t). Bar graphs are the 12-h average of data shown in corresponding line graph, separated
into light and dark phases of the light cycle. Data shown are average ± standard error. Unpaired Student’s t-test was used to compare WT and PGKO
at the same light/dark phase (n= 8, 7 males; n= 10, 14 females). *p < 0.05 was considered significant; additional p-values are indicated for clarity
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satiety is context-dependent26,28,29. The bioavailability
of α-MSH and β-EP is, in part, determined by the
expression of POMC and the subsequent proteolytic
processing by PC1, PC2, and Cpe. We measured α-
MSH, β-EP, and POMC neuropeptides in the medio-
basal hypothalamic samples from mice fed HFD for
2 weeks. Prohormone POMC measurement was com-
parable between sexes and genotypes (Fig. 5a). PGKO
mice, especially female knockouts, have increased
POMC-derived α-MSH and β-EP (Fig. 5b, c). This led to
greater α-MSH:POMC and β-EP:POMC ratios in PGKO
mice (Fig. 5d–e). Pomc transcript as well as other
appetite regulating peptides, Agrp, Pmch, and Npy, were
similar in females (Fig. 5f). Since POMC transcripts and
peptide were similar or trending downward, we con-
clude that the observed increases in α-MSH and β-EP
are not a result of increased POMC synthesis and may
result from effects on POMC processing. In addition,
there is evidence that endogenous β-EP may comple-
ment the anorexigenic actions of α-MSH under certain
conditions28. Taken together, we conclude that higher
levels of hypothalamic α-MSH increases the anorexi-
genic tone in PGKO mice.
Spontaneous action potential frequency is increased in
POMC neurons from PGKO mice
Since increased electrical activity in POMC neurons
suppresses appetite5, we used whole cell patch clamp
recording in acute brain slices to measure spontaneous
activity of POMC neurons in WT and PGKO mice. Gpr17
knockout neurons displayed a higher frequency of spon-
taneous action potentials (Fig. 5g, j) and depolarized
resting membrane potential (p= 0.08) (Fig. 5h, j) at basal
conditions, but similar AP threshold (Fig. 5i). Then, in
order to determine the intrinsic capacity of POMC neu-
rons to be excited by evoked current, we measured the
frequency of evoked action potentials (APs) (Fig. 5k),
which showed comparable results. We conclude that the
increased spontaneous neuronal firing of POMC neurons
contributes to the increased anorexigenic tone in
PGKO mice.
It has been previously reported that a subset of Agrp/
Npy neurons in the ARH express Pomc during develop-
ment30, which could result in Gpr17 deletion from a
subset of Agrp/NPY neurons. To determine the relative
number of AgRP/NPY neurons with Gpr17 deletion,
we used Npy-Gfp to label AgRP/NPY neurons and
Fig. 4 PGKO mice resisted weight and adiposity gained from long-term HFD. Left-hand figures are male data, right-hand figures are female
data. Terminal body weight was measured in male (a) and female (c) mice after 8 and 10 months of HFD, respectively. Fat pad (i.e., epididymal white
adipose tissue, EWAT) was dissected from euthanized mice and weighed for males (b) and females (d). Body weight was assessed at the time of
indirect calorimetry and 5-months post calorimetry (see Fig. 3) for males (e) and females (g). The difference between these two time points (i.e.,
weight gain) was calculated for males (f) and females (h). Data shown are average ± standard error. Statistics were calculated with student’s t-test
(n= 7, 8 male; n= 9, 11 female). *p < 0.05 was considered significant; **p < 0.01, additional p-values are indicated for clarity
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Rosa-tdTomato as a reporter for Pomc-Cre. We were able
to identify that ~1/3 of labeled POMC neurons expressed
Npy-Gfp (Fig. S3A, C). We found that AgRP/NPY neurons
in PGKO mice had similar spontaneous action potential
(sAP) and resting membrane potential (RMP, Fig. S3D, E).
Transcripts encoding orexigenic and anorexigenic neu-
ropeptides had no statistical differences (Fig. 5f). We
concluded that Gpr17 deletion in the subset of AgRP/
NPY neurons does not change the orexigenic tone for
PGKO mice on NCD.
Leptin signaling in the arcuate cells of PGKO mice
Leptin increases the excitability of POMC neurons and
thus promotes satiety31. Therefore, we determined if
altered leptin signaling may explain the improved energy
balance in Gpr17-deficient mice. In order to determine if
PGKO mice had altered sensitivity to leptin in the arcuate
nucleus, we used immunohistochemistry to quantify
leptin signaling by measuring downstream Stat3 phos-
phorylation (pStat3). After refeeding, the number of
pStat3+ cells (Fig. S4A, B) and the intracellular pStat3
intensity (Figure S4 C) were modestly increased in PGKO
sections, suggesting that PGKO mice have normal sen-
sitivity to leptin on NCD. In HFD-fed mice, the con-
centration of circulating leptin was unchanged after
refeeding (Fig. S4D, E), which suggests that PGKO mice
retain normal sensitivity to leptin signaling in the arcuate
nucleus.
Discussion
Our POMC neuron-specific Gpr17 knockout model
reveals a physiological role for Gpr17 signaling in reg-
ulating energy homeostasis through POMC neurons.
PGKO mice were protected from diet-induced obesity,
which resulted in lower total body weight and lower
EWAT mass for both males and females. Interestingly,
female PGKO mice were more protected from long-term
obesity than males. We used functional assays of
POMC neurons to determine the cellular mechanisms
underlying the metabolic phenotypes. We observed
Fig. 5 PGKO mice have increased POMC processing and POMC neuronal activity. a–e POMC-derived peptides from mediobasal hypothalamic
blocks were measured in PGKO and control mice fed HFD for 2 weeks. POMC per mg total protein (a), α-MSH per mg total protein (b), and β-EP per
mg total protein (c), α-MSH:POMC ratio (d), β-EP:POMC ratio (e), n= 4, 5 males; n= 4, 2 females. f Hypothalamic mRNA in female mice on HFD.
g–k Electrophysiology recordings from fluorescently labeled POMC neurons from PGKO and control mice fed HFD for 2 weeks. g Number of
spontaneous action potentials in POMC neurons. Mean RMP and AP threshold were measured in PGKO and control mice (h, i, respectively). j (top)
Representative traces showing action potential (AP) firing and resting membrane potential (RMP) in POMC neurons. j (bottom) Protocol showing no
current was injected when acquiring spontaneous AP recordings. k Number of action potentials evoked by stepwise increases in current amplitude.
Electrophysiology recordings were collected from three WT and five KO neurons from male mice. Statistics were performed with two-way ANOVA
and Sidak post hoc test (a–e) or student’s t-test (g–k); *p < 0.05 was considered significant; ***p < 0.001
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sex-dependent increases in POMC-derived peptides
(α-MSH and β-EP) from hypothalamic extracts collected
after 2 weeks of HFD exposure in PGKO mice. Our
electrophysiological results showed that the spontaneous
firing of Gpr17-deficient POMC neurons was increased.
We concluded that Gpr17 deletion increased the POMC
neuronal activity and promoted better energy home-
ostasis that curtailed weight gain, especially in female
mice. Since male PGKO mice had only partial increases
in POMC-derived peptide production compared with
female PGKO mice, they were less protected from
weight gain.
Sexual dimorphism is well documented for metabolic
regulation. Estrogen signaling has been reported as the
underlying cause for the gender-specific modulation of
abdominal adiposity32, adipose tissue lipolysis33, and
hepatic glucose metabolism34. The gender-specific dif-
ference in metabolism is more evident with HFD feeding
in the adipose and brain tissues34–36. Of note, the
quantity and physiology of hypothalamic POMC neu-
rons are sex-dependent. In females, POMC neurons are
more numerous, have increased electrical activity, and
elevated hypothalamic expression of POMC transcript
and protein23,37. Biological mechanisms regulating
POMC neurons are also sex-specific. Leptin signaling in
POMC neurons (which increases POMC neuronal fir-
ing) also has sex-dependent effects on adipose acquisi-
tion, energy expenditure, peripheral glucose tolerance,
and locomotor activity38. Moreover, estrogen modulates
food intake through receptors expressed by POMC
neurons39. Elucidating how targeting specific signaling
pathway in hypothalamic neurons to improve energy
homeostasis in a gender-specific manner warrants future
investigation.
Hypothalamic neurocircuits, including POMC neu-
rons, have been shown to increase autonomic outflow to
peripheral organs, which increases lipolysis in adipose
tissues and insulin release by pancreatic islets40–43. Our
approach for conditional deletion of Gpr17 in POMC
neurons resulted in alterations in liver mRNAs related to
glucose utilization. This data is consistent with previous
findings that connect POMC neuronal activity with
hepatic glucose production and insulin sensitivity. For
example, chemogenetic stimulation of POMC neurons
rapidly induced sympathetic nerve activity to the liver44.
Central administration of α-MSH increases hepatic
gluconeogenesis and the requisite enzymes Pepck and
G6pase45. The vagal nerve, which connects brain and
liver, suppresses hepatic glucose production46. More-
over, insulin action in the CNS alters hepatic glucose
production and requires vagal efferents46. Therefore,
liver mRNAs that are upregulated in PGKO mice could
be a direct consequence of altered POMC neuronal
activity.
It is also important to note that several age-related
mechanisms impair POMC neuronal function and con-
tribute to obesity. Gpr17 knockout may restore some of
these pathways that are eroded by aging19. For example, as
mice age, POMC neurons are electrically silenced by
elevated activation of mTOR and hyperactive KATP
channels47. HFD-fed obese mice have severe leptin
resistance in POMC neurons48. The synaptic input from
AgRP/NPY neurons to POMC neurons increases47,48,
which progressively increases orexigenic tone in older
mice49. In our study, PGKO mice, especially females, were
protected from adiposity gained due to age and HFD
feeding. Although males did not have an apparent change
in energy homeostasis, female PGKO mice had increased
energy expenditure, nighttime locomotor activity, and
increased glucose utilization. It is possible that deficiency
in Gpr17 signaling protects against conditions that silence
POMC neurons, such as HFD and age.
Our group published previously that Gpr17 substantially
altered energy homeostasis in AgRP neuron-specific Gpr17
knockout mice20. Since AgRP and POMC neurons have
opposing actions on energy homeostasis, one of our prin-
ciple research questions was whether Gpr17 activity in
POMC neurons counteracted that of AgRP neurons. In this
regard, PGKO mice surprisingly also had a favorable effect
on obesity. One possible explanation is that AgRP condi-
tional knockout mice had enhanced leptin sensitivity of
ARH neurons, which was also the trend in PGKO mice.
Since leptin signaling oppositely regulates AgRP and
POMC neuronal activity, both mice may have favorable
metabolic profiles due to sensitization to leptin. The fact
that Gpr17 knockout produced positive, but unique,
metabolic outcomes in Agrp and Pomc conditional
knockout mice supports its potential role as a target for
obesity therapy.
In addition, Gpr17 expression is not restricted to POMC
and AgRP neurons. Other groups have identified its roles in
myelination and metabolic role in oligodendrocytes50,
mitigating ageing-related defects and ischemic damage in
the brain19,51 and heart52. The inconsistent report on
whole-body Gpr17 knockout50,53 is probably due to the
physiological compensation and developmental adaption
that are often associated with germ-line knockouts, which
limits the interpretation of negative data as a true absence
of a function54. Therefore, our studies using conditional
knockout mice provide insights on the metabolic function
of this orphan GPCR. Future studies with conditional
knockout in peripheral tissues are warranted in order to
understand the integrative physiology of Gpr17.
In conclusion, our results suggest a role for Gpr17 in
regulating energy homeostasis and metabolism through
POMC neurons. Thus, eliminating the endogenous ago-
nist or supplying antagonists of Gpr17 could be ther-
apeutically relevant strategies for managing obesity.
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